Healthcare | August 02, 2021
Krsnaa Diagnostics public issue opens from Aug 4-6th 2021
Price band in the range of Rs 933 to Rs 954
Price band in the range of Rs 933 to Rs 954
The contribution of Wockhardt at Wrexham is one of the best examples of the success and significant potential of India-UK partnerships in the healthcare sector
The first six batches are being shipped to the Gamaleya Center, Moscow for the quality approval
The company is confident of commencing production at both Mahad and Chiplun units soon
Earlier, the USFDA has granted ‘Orphan Drug Designation’ and ‘Fast Track Designation’ to Saroglitazar Mg for PBC
As per the agreement, Lonza will provide commercial-scale manufacture of monoclonal antibodies
Sumatriptan Injection USP is indicated in adults for acute treatment of migraine with or without aura, and acute treatment of cluster headache
The company has already embarked upon significant expansion in Turkey
The company has a cumulative total of 147 ANDA approvals (129 final approvals and 18 tentative approvals) from USFDA
The companies anticipate clinical studies to begin in August, subject to regulatory approvals
Subscribe To Our Newsletter & Stay Updated
